Research Index
HGH Fragment 176-191 Research Index
PSI surfaces 19 peer-reviewed studies on HGH Fragment 176-191, prioritized by evidence strength: human clinical research first, then animal studies. The full historical archive is linked below on PubMed.
19 studies
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
Dominikowski A, Rękoś Z, Olejarz M et al.
Front Endocrinol (Lausanne)·2026·Human·GH Activity·PubMed →
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Mendias CL, Awan TM
Sports Med·2026·Review·PubMed →
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Rahman OF, Lee SJ, Seeds WA
J Am Acad Orthop Surg Glob Res Rev·2026·Review·Wound Healing·PubMed →
Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells.
Habibullah MM, Mohan S, Syed NK et al.
Drug Des Devel Ther·2022·Animal·GH Activity·PubMed →
Human sports drug testing by mass spectrometry.
Schänzer W, Thevis M
Mass Spectrom Rev·2017·Review·GH Activity·PubMed →
Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.
Thomas A, Görgens C, Guddat S et al.
J Sep Sci·2016·Animal·PubMed →
Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.
Kwon DR, Park GY
Ann Clin Lab Sci·2015·Animal·Anti-Inflammatory, Osteoarthritis·PubMed →
Detection and in vitro metabolism of AOD9604.
Cox HD, Smeal SJ, Hughes CM et al.
Drug Test Anal·2015·Animal·PubMed →
Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604.
Vanhee C, Moens G, Deconinck E et al.
Drug Test Anal·2014·Human·PubMed →
Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.
Thevis M, Thomas A, Schänzer W
Expert Rev Proteomics·2014·Animal·PubMed →
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.
Thevis M, Schänzer W
J Pharm Biomed Anal·2014·Review·PubMed →
AOD-9604 does not influence the WADA hGH isoform immunoassay.
Orlovius AK, Thomas A, Schänzer W et al.
Drug Test Anal·2013·Animal·GH Activity·PubMed →
Obesity drugs in clinical development.
Halford JC
Curr Opin Investig Drugs·2006·Review·Weight Loss·PubMed →
Gateways to clinical trials.
Bayés M, Rabasseda X, Prous JR
Methods Find Exp Clin Pharmacol·2005·Animal·PubMed →
AOD-9604 Metabolic.
Wilding J
Curr Opin Investig Drugs·2004·Review·Weight Loss·PubMed →
Gateways to clinical trials.
Bayes M, Rabasseda X, Prous JR
Methods Find Exp Clin Pharmacol·2003·Animal·PubMed →
Gateways to clinical trials.
Bayés M, Rabasseda X, Prous JR
Methods Find Exp Clin Pharmacol·2003·Animal·PubMed →
The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.
Heffernan M, Summers RJ, Thorburn A et al.
Endocrinology·2001·Animal·Weight Loss, GH Activity·PubMed →
Hyperglycemic action of synthetic C-terminal fragments of human growth hormone.
Ng FM, Bornstein J
Am J Physiol·1978·Animal·Glycemic Control, GH Activity·PubMed →